
Proceedings of the National Academy of Sciences, Journal Year: 2025, Volume and Issue: 122(20)
Published: May 9, 2025
Language: Английский
Proceedings of the National Academy of Sciences, Journal Year: 2025, Volume and Issue: 122(20)
Published: May 9, 2025
Language: Английский
Proceedings of the National Academy of Sciences, Journal Year: 2025, Volume and Issue: 122(20)
Published: May 9, 2025
Language: Английский
Citations
1Clinical and Translational Medicine, Journal Year: 2025, Volume and Issue: 15(3)
Published: March 1, 2025
Abstract Background Gastric cancer is one of the most prevalent malignant tumors within digestive system, and ferroptosis playing a crucial role in its progression. Glutathione peroxidase 4 (GPX4), key negative regulator ferroptosis, highly expressed gastric contributes to tumor growth. Targeting regulation GPX4 has emerged as promising approach induce develop effective therapy for cancer. Methods To confirm that OTUD5 deubiquitinase regulates we performed Western blotting, Co‐IP, immunofluorescence, quantitative real‐time PCR, Ub assay flow cytometry experiments. explore physiological function OUTD5, knocked out Otud5 gene mouse cell line (MFC) using CRISPR‐Cas9 eatablished subcutaneous tumour model. Immunohistochemistry (IHC) analysis was used inveatigate pathological correlation human Results We report ovarian domain‐containing 5 (OTUD5) interacts with, deubiquitylates stabilizes GPX4. depletion destabilizes GPX4, promotes lipid peroxidation sensitizes cells ferroptosis. Moreover, p53 activator nutlin‐3a suppresses transcription, leading degradation cells. Notably, only wild‐type capacity inhibit while mutations or deficiencies correlate with increased expression, promoting Additionally, silencing nutlin‐3a‐induced enhances sensitivity vivo. Subsequently, p53/OTUD5/GPX4 axis confirmed clinical samples. Conclusion Collectively, these findings elucidate mechanism whereby inactivation upregulates transcription deubiquitylate stablize resulting inhibition This discovery highlights potential therapeutic value targeting promote p53‐inactivated Key points mediates deubiquitination regulate stability. Deletion inhibits Wild type thereby inhibiting development OTUD5, expression activity are correlated correlates progression STAD.
Language: Английский
Citations
0Cell Reports, Journal Year: 2025, Volume and Issue: 44(5), P. 115681 - 115681
Published: May 1, 2025
Language: Английский
Citations
0Proceedings of the National Academy of Sciences, Journal Year: 2025, Volume and Issue: 122(20)
Published: May 9, 2025
Language: Английский
Citations
0